SCHEMBL24786348

SCHEMBL24786348

CCOC(=O)c1cnc(Cl)nc1NC12CC3CC(C1)CC(C(=O)OC(C)(C)C)(C3)C2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 3/20 0.44
▸ POLB P06746 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ ESR2 Q92731 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.40
▸ CNR2 P34972 1/20 0.37
▸ NFKB1 P19838 4/20 0.35
▸ ATF1 P18846 1/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MAPK8 P45983 1/20 0.35
▸ STK17B O94768 1/20 0.34
▸ STK17A Q9UEE5 1/20 0.34
▸ NPSR1 Q6W5P4 3/20 0.34
▸ NR2F2 P24468 2/20 0.34
▸ MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28667854 1.00 SYK (0.44) SYKPOLBMAPTMEN1KMT2A
SCHEMBL30236562 1.00 SYK (0.44) SYKPOLBMAPTMEN1KMT2A
SCHEMBL28667855 1.00 SYK (0.44) SYKPOLBMAPTMEN1KMT2A
SCHEMBL24786905 0.88 SYK (0.42) SYKPOLBMAPTMEN1KMT2A
SCHEMBL23618810 0.88 POLB (0.39) SYKPOLBMAPTMEN1KMT2A
SCHEMBL23618785 0.84 GSK3A (0.44) SYKPOLBMAPTMEN1KMT2A
SCHEMBL31612079 0.82 SYK (0.49) SYKMAPTMEN1KMT2AKDM4E
SCHEMBL23618710 0.81 SYK (0.44) SYKPOLBMAPTMEN1KMT2A
SCHEMBL30235825 0.81 SYK (0.44) SYKPOLBMAPTMEN1KMT2A
SCHEMBL24786349 0.77 SYK (0.44) SYKMAPTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117377676-A Crystalline forms of purine derivatives and pharmaceutical compositions thereof 成都百裕制药股份有限公司 2024-01-09 — — CN disclosed
CN-113121574-B Purine derivatives and their use in medicine 成都百裕制药股份有限公司 2023-02-17 — — CN disclosed
WO-2023274310-A1 CRYSTAL FORM OF PURINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF 成都百裕制药股份有限公司 2023-01-05 — — WO disclosed
US-20220402920-A1 PURINE DERIVATIVE AND MEDICAL USE THEREOF KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD. (CN) 2022-12-22 — — US disclosed
CN-113121574-A Purine derivatives and their use in medicine 成都百裕制药股份有限公司 2021-07-16 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220402920-A1 PURINE DERIVATIVE AND MEDICAL USE THEREOF DPYD, PNP, TYMP SYK 1822/4885POLB 85/4885MAPT 3496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback